Elimination of critical substances
Within this roadmap process, we check whether the critical substances in the respective products can be replaced by a safer alternative. For the substitution, we focus on innovating safe and sustainable alternatives. Therefore, we do not switch to other substances, which from an expert view might have comparable hazardous properties but have not been restricted yet.
If a replacement by a safe alternative is not possible, and if according to our scientists or regulatory bodies, the concerns or risks are beyond reasonable levels, we will phase out the substances. If critical substances in essential uses cannot be replaced, we will implement risk mitigating measures based on scientifically acceptable levels. Examples for phase out decisions can be found below:
